Discontinued — last reported Q2 '16

Other

Tax receivable within other current assets

Veradermics Tax receivable within other current assets decreased by 3.3% to $1.21M in Q1 2026 compared to the prior quarter.

Analysis

StatementBalance Sheet Statement
SectionOther
CategoryLiquidity
SignalContext dependent
VolatilityModerate
First reportedQ4 2014
Last reportedQ2 2016

How to read this metric

An increase may indicate overpayment of estimated taxes or the realization of tax credits, while a decrease suggests the collection of these receivables or a shift in tax liability status.

Detailed definition

This represents the amount of income tax overpayments or credits due to the company from tax authorities that are expect...

Peer comparison

Common across all capital-intensive industries; peers typically report this within current assets or as a component of other receivables.

Metric ID: other_income_taxes_receivable

Historical Data

2 periods
 Q4 '25Q1 '26
Value$1.26M$1.21M
QoQ Change-3.3%
Range$1.21M$1.26M

Frequently Asked Questions

What is Veradermics 's tax receivable within other current assets?
Veradermics (MANE) reported tax receivable within other current assets of $1.21M in Q1 2026.
What does tax receivable within other current assets mean?
Income tax refunds or credits owed to the company by tax authorities.